JPH0561251B2 - - Google Patents

Info

Publication number
JPH0561251B2
JPH0561251B2 JP63175354A JP17535488A JPH0561251B2 JP H0561251 B2 JPH0561251 B2 JP H0561251B2 JP 63175354 A JP63175354 A JP 63175354A JP 17535488 A JP17535488 A JP 17535488A JP H0561251 B2 JPH0561251 B2 JP H0561251B2
Authority
JP
Japan
Prior art keywords
azt
aids
pharmaceutically acceptable
administered
arc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP63175354A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6438030A (en
Inventor
Yoshiko Yokota
Yasuhiro Mine
Yoshimi Wakai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of JPS6438030A publication Critical patent/JPS6438030A/ja
Publication of JPH0561251B2 publication Critical patent/JPH0561251B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP63175354A 1987-07-29 1988-07-13 Preventing and treating agent for aids Granted JPS6438030A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878717955A GB8717955D0 (en) 1987-07-29 1987-07-29 Prevention & treatment of aids

Publications (2)

Publication Number Publication Date
JPS6438030A JPS6438030A (en) 1989-02-08
JPH0561251B2 true JPH0561251B2 (enExample) 1993-09-06

Family

ID=10621470

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63175354A Granted JPS6438030A (en) 1987-07-29 1988-07-13 Preventing and treating agent for aids

Country Status (3)

Country Link
US (1) US5059592A (enExample)
JP (1) JPS6438030A (enExample)
GB (1) GB8717955D0 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229368A (en) * 1987-07-29 1993-07-20 Fujisawa Pharmaceutical Co., Ltd. Composition for prevention and (or) treatment of Aids
JPH089537B2 (ja) * 1990-10-05 1996-01-31 ヴエルナー・ランゲ エイズ治療薬
DK0513917T4 (da) * 1991-05-16 2001-06-25 Glaxo Group Ltd Antivirale kombinationer indeholdende nukleosidanaloger
US20050220862A1 (en) * 2004-03-31 2005-10-06 Bernstein Joel E Compositions with reduced hepatotoxicity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322341A (en) * 1980-05-13 1982-03-30 Fujisawa Pharmaceutical Co Peptide, process for preparation thereof and use thereof
JPS60104019A (ja) * 1983-11-10 1985-06-08 Fujisawa Pharmaceut Co Ltd ウイルス感染症用薬剤

Also Published As

Publication number Publication date
US5059592A (en) 1991-10-22
JPS6438030A (en) 1989-02-08
GB8717955D0 (en) 1987-09-03

Similar Documents

Publication Publication Date Title
KR960016582B1 (ko) 위장장해의 치료 및 예방용 약제학적 조성물
JP2829545B2 (ja) ２’３’―ジデオキシイノシンによるヒトのレトロウィルス感染症の治療
WO1999053928A1 (en) Treatment of iatrogenic and age-related hypertension and pharmaceutical compositions useful therein
WO1999066917A2 (en) Composition comprising ss-hydroxy-ss-methylbutyric acid and at least one amino acid
JP2019504857A (ja) Ｈｉｖおよびエイズの治療および予防方法
EP0786993B1 (en) Compositions comprising carbonate/bicarbonate buffered dichloroacetic acid and their use in the treatment of metabolic and cardiovascular disorders
JP2003286170A (ja) アムロジピン、アムロジピン塩、もしくはフェロジピンとａｃｅ阻害薬とを含有する組成物
CZ355897A3 (cs) Způsob léčení mánie a bipolárních poruch
JP2006511538A (ja) 非ヌクレオシド系逆転写酵素阻害剤（ｎｎｒｔｉ）とプロテアーゼ阻害剤などのシトクロムｐ４５０の阻害剤とを含む組み合わせの使用
JPH0561251B2 (enExample)
US4794112A (en) Acetaminophen/hydroxyzine analgesic combinations
PL190505B1 (pl) Kompozycja farmaceutyczna i sposób jej wytwarzania
ROSENBLATT Antiparasitic agents
NL8105635A (nl) Geneesmiddel met transplantaatafstotings- en/of immunologische ontstekingsremmende werking, alsmede werkwijze voor de remming van transplantaatafstoting en/of immunologische ontsteking.
US6649644B1 (en) Method of treating HIV infection by combined use of a cytotoxic agent and a non-nucleoside reverse transcriptase inhibitor
JPH0219093B2 (enExample)
JP2006523685A (ja) 循環器疾患の治療のためのｌ−カルニチンの使用
US5229368A (en) Composition for prevention and (or) treatment of Aids
JP2000186040A (ja) 抗ｈｉｖ感染症剤
KR20070086007A (ko) 당뇨병의 치료를 위한 의약 조성물
US3932652A (en) Antidepressant compositions
JP2023518430A (ja) 感染症の治療におけるブシラミンの使用
EP1155694A1 (en) Anti-hiv infection agents and method for treating hiv infection
Durivage et al. Prevention and management of toxicities associated with antineoplastic drugs
TW202606651A (zh) 用於預防或治療認知功能不全的苯甲酸鹽